Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarkko J Lackman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmacological Research|December 21, 2013
Targeting opioid receptors with pharmacological chaperonesUlla E Petäjä-Repo, Jarkko J Lackman
The Journal of Biological Chemistry|May 7, 2014
N-Glycan-dependent and -independent quality control of human δ opioid receptor N-terminal variantsJarkko J Lackman, Piia M H Markkanen, Mireille Hogue, et al.
The Journal of Biological Chemistry|December 21, 2011
Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerizationTarja T Leskelä, Jarkko J Lackman, Miia M Vierimaa, et al.
Cellular Signalling|November 4, 2017
Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membraneJarkko J Lackman, Christoffer K Goth, Adnan Halim, et al.
The Biochemical Journal|October 18, 2018
The N-terminal domain of unknown function (DUF959) in collagen XVIII is intrinsically disordered and highly O-glycosylatedInderjeet Kaur, Salla Ruskamo, Jarkko Koivunen, et al.
Molecular Pharmacology|October 16, 2012
β-Adrenergic agonists mediate enhancement of β1-adrenergic receptor N-terminal cleavage and stabilization in vivo and in vitroAnna E Hakalahti, Hamayun Khan, Miia M Vierimaa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 27, 2021
GPR37 is processed in the N-terminal ectodomain by ADAM10 and furinS Orvokki Mattila, Hanna E Tuhkanen, Jarkko J Lackman, et al.
The Journal of Biological Chemistry|February 8, 2017
Site-specific <i>O</i>-Glycosylation by Polypeptide <i>N</i>-Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulates β<sub>1</sub>-Adrenergic Receptor N-terminal CleavageChristoffer K Goth, Hanna E Tuhkanen, Hamayun Khan, et al.
International Journal of Molecular Sciences|October 16, 2024
Chemokine Receptor N-Terminus Charge Dictates Reliance on Post-Translational Modifications for Effective Ligand Capture and Following Boosting by Defense PeptidesTing Xu, Anne Sophie Schou, Jarkko J Lackman, et al.
The FEBS Journal|August 29, 2024
Altered O-glycosylation of β<sub>1</sub>-adrenergic receptor N-terminal single-nucleotide variants modulates receptor processing and functional activityHanna E Tuhkanen, Ilona J Haasiomäki, Jarkko J Lackman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacological Research|December 21, 2013
Targeting opioid receptors with pharmacological chaperonesUlla E Petäjä-Repo, Jarkko J Lackman
The Journal of Biological Chemistry|May 7, 2014
N-Glycan-dependent and -independent quality control of human δ opioid receptor N-terminal variantsJarkko J Lackman, Piia M H Markkanen, Mireille Hogue, et al.
The Journal of Biological Chemistry|December 21, 2011
Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerizationTarja T Leskelä, Jarkko J Lackman, Miia M Vierimaa, et al.
Cellular Signalling|November 4, 2017
Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membraneJarkko J Lackman, Christoffer K Goth, Adnan Halim, et al.
The Biochemical Journal|October 18, 2018
The N-terminal domain of unknown function (DUF959) in collagen XVIII is intrinsically disordered and highly O-glycosylatedInderjeet Kaur, Salla Ruskamo, Jarkko Koivunen, et al.
Molecular Pharmacology|October 16, 2012
β-Adrenergic agonists mediate enhancement of β1-adrenergic receptor N-terminal cleavage and stabilization in vivo and in vitroAnna E Hakalahti, Hamayun Khan, Miia M Vierimaa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 27, 2021
GPR37 is processed in the N-terminal ectodomain by ADAM10 and furinS Orvokki Mattila, Hanna E Tuhkanen, Jarkko J Lackman, et al.
The Journal of Biological Chemistry|February 8, 2017
Site-specific <i>O</i>-Glycosylation by Polypeptide <i>N</i>-Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulates β<sub>1</sub>-Adrenergic Receptor N-terminal CleavageChristoffer K Goth, Hanna E Tuhkanen, Hamayun Khan, et al.
International Journal of Molecular Sciences|October 16, 2024
Chemokine Receptor N-Terminus Charge Dictates Reliance on Post-Translational Modifications for Effective Ligand Capture and Following Boosting by Defense PeptidesTing Xu, Anne Sophie Schou, Jarkko J Lackman, et al.
The FEBS Journal|August 29, 2024
Altered O-glycosylation of β<sub>1</sub>-adrenergic receptor N-terminal single-nucleotide variants modulates receptor processing and functional activityHanna E Tuhkanen, Ilona J Haasiomäki, Jarkko J Lackman, et al.
Pageof 2